BREMELANOTIDE

Drug AMAG Pharmaceuticals, Inc.
Total Payments
$150,033
Transactions
266
Doctors
63
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $150,033 266 63

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $62,983 23 42.0%
Honoraria $57,000 20 38.0%
Travel and Lodging $21,396 102 14.3%
Food and Beverage $8,654 121 5.8%

Top Doctors Receiving Payments for BREMELANOTIDE — Page 3

Doctor Specialty Location Total Records
, M.D Obstetrics & Gynecology Wausau, WI $70.45 1
, M.B.B.S., M.S Obstetrics & Gynecology Bronx, NY $70.45 1
, MD Obstetrics & Gynecology Sarasota, FL $70.45 1
, MD Obstetrics & Gynecology Cleveland, MS $70.45 1
, M.D Obstetrics & Gynecology Thibodaux, LA $70.45 1
, M.D Obstetrics & Gynecology Dallas, TX $70.45 1
, M.D Obstetrics & Gynecology Damascus, MD $70.45 1
, M.D Obstetrics & Gynecology White Plains, MD $70.45 1
, M.D Gynecology New Smyrna Beach, FL $70.45 1
, M.D Obstetrics & Gynecology Norton, VA $70.45 1
, MD Obstetrics & Gynecology Gastonia, NC $70.45 1
, MD Obstetrics & Gynecology San Jose, CA $70.45 1
, MD Obstetrics & Gynecology Fontana, CA $70.45 1
, M.D Cardiovascular Disease Murrieta, CA $68.85 1

About BREMELANOTIDE

BREMELANOTIDE is a drug associated with $150,033 in payments to 63 healthcare providers, recorded across 266 transactions in the CMS Open Payments database. The primary manufacturer is AMAG Pharmaceuticals, Inc..

Payment data is available from 2017 to 2017. In 2017, $150,033 was paid across 266 transactions to 63 doctors.

The most common payment nature for BREMELANOTIDE is "Consulting Fee" ($62,983, 42.0% of total).